BRAF and cancer: In the AUS-other subcategory, not only were PTCs rarer among cancers, but BRAF was also less likely to be positive (only 1/4 PTCs were BRAF-positive among AUS-other nodules vs. 3/4 among AUS-nuclear nodules).